
A co-lyophilized research blend of GHK-Cu (50 mg), BPC-157 (10 mg), and TB-500 / thymosin β4 fragment (10 mg). Supplied as a lyophilized powder in a sealed 70 mg vial for laboratory research use only. Each lot is tested and published with a lot-specific certificate of analysis.
Specifications
Certificate of analysis
Lot verified
LOT PL-2609-043 · PrymaLab Analytical (in-house) · Sep 17, 2026
99.72%
RP-HPLC purity
All products are sold strictly for laboratory research use only. Not for human or veterinary use, not for consumption, and not intended to diagnose, treat, cure, or prevent any disease.